A new role for stress cardiac magnetic resonance imaging in patients with heart failure and preserved ejection fraction.

[1]  J. Garot,et al.  Long-term prognostic value of ischaemia and cardiovascular magnetic resonance-related revascularization for stable coronary disease, irrespective of patient's sex: a large retrospective study. , 2021, European heart journal. Cardiovascular Imaging.

[2]  P. Ponikowski,et al.  Empagliflozin in Heart Failure with a Preserved Ejection Fraction. , 2021, The New England journal of medicine.

[3]  J. McMurray,et al.  2021 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure. , 2021, European heart journal.

[4]  J. Garot,et al.  Long-Term Prognostic Value of Stress CMR in Patients With Heart Failure and Preserved Ejection Fraction. , 2021, JACC. Cardiovascular imaging.

[5]  J. Garot,et al.  Vasodilatation stress cardiovascular magnetic resonance imaging: Feasibility, workflow and safety in a large prospective registry of more than 35,000 patients. , 2021, Archives of cardiovascular diseases.

[6]  A. Cohen-Solal,et al.  Left Atrioventricular Coupling Index to Predict Incident Heart Failure: The Multi-Ethnic Study of Atherosclerosis , 2021, Frontiers in Cardiovascular Medicine.

[7]  D. Mandry,et al.  Position paper on stress cardiac magnetic resonance imaging in chronic coronary syndrome: Endorsed by the Société française de radiologie (SFR), the Société française d'imagerie cardiovasculaire (SFICV) and the Société française de cardiologie (SFC). , 2021, Archives of cardiovascular diseases.

[8]  P. Croisille,et al.  Imaging Interstitial Fibrosis, Left Ventricular Remodeling, and Function in Stage A and B Heart Failure. , 2020, JACC. Cardiovascular imaging.

[9]  J. Garot,et al.  Feasibility and Prognostic Value of Vasodilator Stress Perfusion CMR in Patients With Atrial Fibrillation. , 2020, JACC. Cardiovascular imaging.

[10]  Amit R. Patel,et al.  Cardiac Magnetic Resonance Stress Perfusion Imaging for Evaluation of Patients With Chest Pain , 2019, Journal of the American College of Cardiology.

[11]  Akshay S. Desai,et al.  Coronary microvascular dysfunction and future risk of heart failure with preserved ejection fraction , 2018, European heart journal.

[12]  F. Crea,et al.  The parallel tales of microvascular angina and heart failure with preserved ejection fraction: a paradigm shift. , 2016, European heart journal.

[13]  D. J. Veldhuisen,et al.  Ischaemia in heart failure with preserved ejection fraction; is it important?: Correspondence , 2016 .

[14]  N. Bouabdallaoui,et al.  Vascular and Microvascular Endothelial Function in Heart Failure With Preserved Ejection Fraction. , 2016, Journal of cardiac failure.

[15]  V. Melenovský,et al.  Implications of coronary artery disease in heart failure with preserved ejection fraction. , 2014, Journal of the American College of Cardiology.

[16]  B. Jude,et al.  Renal resistance index and its prognostic significance in patients with heart failure with preserved ejection fraction. , 2011, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

[17]  R. Bonow,et al.  Coronary artery disease in patients with heart failure and preserved systolic function. , 2002, The American journal of cardiology.